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Abstract
Background: Better information on the typical course and management of acute common infections in the
community could inform antibiotic stewardship campaigns. We aimed to investigate the incidence, management,
and natural history of a range of infection syndromes (respiratory, gastrointestinal, mouth/dental, skin/soft tissue,
urinary tract, and eye).
Methods: Bug Watch was an online prospective community cohort study of the general population in England
(2018–2019) with weekly symptom reporting for 6 months. We combined symptom reports into infection
syndromes, calculated incidence rates, described the proportion leading to healthcare-seeking behaviours and
antibiotic use, and estimated duration and severity.
Results: The cohort comprised 873 individuals with 23,111 person-weeks follow-up. The mean age was 54 years
and 528 (60%) were female. We identified 1422 infection syndromes, comprising 40,590 symptom reports. The
incidence of respiratory tract infection syndromes was two per person year; for all other categories it was less than
one. 194/1422 (14%) syndromes led to GP (or dentist) consultation and 136/1422 (10%) to antibiotic use. Symptoms
usually resolved within a week and the third day was the most severe.
Conclusions: Most people reported managing their symptoms without medical consultation. Interventions
encouraging safe self-management across a range of acute infection syndromes could decrease pressure on
primary healthcare services and support targets for reducing antibiotic prescribing.
Keywords: Antibiotic stewardship, common infections, Incidence, healthcare-seeking behaviour, community cohort
studies
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Background
Antimicrobial resistance (AMR) is a serious global prob-
lem that has resulted in increasing numbers of infections
becoming untreatable [1]. There were over 60,000 severe
antibiotic resistant infections in England in 2018; ap-
proximately 165 new antibiotic resistant infections per
day [2]. As AMR is largely driven by selective pressure
exerted through antibiotic use [1], ensuring that antibi-
otics are used responsibly (antibiotic stewardship) is a
priority [3]. Antibiotic prescribing in England reduced
by 9% from 2014 to 2018, but the number of drug-
resistant infections continues to rise [2]. The UK’s na-
tional action plan on tackling AMR aims to further re-
duce prescribing by 15% by 2024 whilst reducing the
number of drug-resistant infections [4].
Achieving this aim requires identification of opportun-
ities to safely reduce prescribing. The majority of anti-
biotic prescribing in England is in general practice,
followed by hospitals, other community settings, and
dental practice [2]. Most prescriptions made in general
practice are for infections of the respiratory tract, uro-
genital tract, and skin/wounds [5]. It has been estimated
that up to 23% of prescriptions in general practice, and
over half of those in dental practice, are inappropriate
[6, 7]. This includes prescriptions for mild illnesses that
would get better on their own and has led to initiatives
to reduce inappropriate prescribing in primary care, and
efforts to understand levels of knowledge of antibiotic
stewardship amongst professionals and the general pub-
lic [8, 9]. Encouraging patients to manage their symp-
toms without medical consultation could be an effective
complementary approach to reducing antibiotic
prescribing.
There is evidence from large-scale community cohort
studies in England that most people can safely self-
manage respiratory and gastrointestinal infections with-
out visiting a GP: The Flu Watch study estimated that
21% of influenza-like illnesses led to a GP consultation
[10], and the IID2 study found approximately one GP
consultation for every 15 cases of infectious intestinal
disease in the community [11]. This abundance of un-
detected community cases is referred to as a clinical
“iceberg” of infection and has been used as a evidence
for promoting safe self-management of these symptoms
[12]. However, there is limited information on how
people manage symptoms of other common infections
as similar large-scale studies have not been conducted.
Information on the usual duration of symptoms has
also been used to develop educational resources for anti-
biotic stewardship campaigns. For example, Public
Health England’s Keep Antibiotics Working campaign
lists how long most people take to recover from five
common illnesses (cough, cold, ear ache, sore throat,
and sinusitis) with guidance on what to do if symptoms
persist [13]. Establishing these estimates for a wider
range of infections requires information on the typical
duration of symptoms in the community (i.e., including
episodes of symptoms that do not lead to healthcare
consultation). Measuring the impacts of infections on
quality of life can also inform health economic assess-
ments of potential interventions. Data from the Flu
Watch study has been used to generate these estimates
for influenza-like illnesses [14] but there is a lack of
similar information for other infections.
Bug Watch was a prospective community cohort study
in England in 2018–2019 that collected information on
symptoms of a range of acute common infections (re-
spiratory, gastrointestinal, mouth/dental, skin/soft tissue,
urinary tract, and eye) [15]. We quantified the incidence
of these common infection syndromes in the commu-
nity, determined the proportions of syndromes that led
to various healthcare-seeking behaviours and antibiotic
use, and estimated the average duration of symptoms
and their impacts on health-related quality of life.
Methods
Study design, recruitment and data collection
This was an online prospective community cohort study
in England. Full details of the study design are described
in the protocol [15]. Briefly, we recruited participants
through the Health Survey for England (HSE), an annual
survey designed to be representative of the population
living in private households in England [16]. We sent in-
vitation letters to all adults who had taken part in HSE
in 2013, 2014 or 2015 and had consented to be con-
tacted about future research (87% participants). Parents
or guardians were asked to register their children aged
under 16 (and completed all surveys on their behalf),
and any other adults living in the household were invited
to register separately. Recruitment was conducted in
four waves in March, June, September and November
2018.
Study registration consisted of an online consent form
and baseline survey. Baseline data included contact de-
tails, demographics, information on general health, num-
ber of GP consultations in the last year, health-related
quality of life (adults only, measured using the EQ-5D-
3L instrument [17]) and questions on knowledge and at-
titudes towards antibiotics (adapted from the 2015 Well-
come Trust Monitor survey) [18].
During follow-up, participants were asked to keep
track of symptoms of infection prospectively using a
laminated symptom diary which we sent to them after
registration. This included 44 symptoms of infection in
seven categories: Non-specific, respiratory, gastrointes-
tinal, mouth/dental, skin/soft tissue, urinary tract, and
eye. Each week, participants were then emailed a link to
an online survey to report which symptoms (if any) they
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had on each day. If they had no symptoms in a particular
week, they reported this through a very short survey.
They were also asked to report associated healthcare-
seeking behaviours (GP consultation in person or by
telephone, nurse at GP practice, going to hospital, going
to a walk-in centre, using an internet doctor, using the
NHS 111 service (a free, 24 h non-emergency medical
helpline), visiting a pharmacy, looking for information
on the internet, or going to the dentist), health-related
quality of life (adults only, using EQ-5D-3L), and anti-
biotic use. Participants were followed-up for 6 months.
Data were collected using Research Electronic Data
Capture (REDCap) [19] surveys hosted on the UCL Data
Safe Haven, which is certified to the ISO27001 informa-
tion security standard and conforms to NHS Digital’s In-
formation Governance Toolkit. This study was given
ethical approval by the UCL Research Ethics Committee
(ID 11813/001).
Statistical analysis
We calculated the overall proportion of people who
responded to the survey invitation and the proportion of
weekly surveys completed by each individual. Partici-
pants who completed fewer than 75% of weekly surveys
were excluded from the analysis. We described the base-
line characteristics of the cohort and compared them
with those who signed up but were excluded. We also
assessed population representativeness by comparing,
where relevant, with census population estimates, HSE
data, and results from the Wellcome Trust Monitor sur-
vey [18].
In our population of participants who completed at
least 75% of surveys, we identified infection syndromes
(i.e. combinations of symptoms associated with one po-
tential infection episode) by combining reports of spe-
cific and non-specific symptoms across different days. A
new infection syndrome in a given category was defined
when a symptom was reported for the first time or more
than 10 days after a previous syndrome (Figure S1). A
10 day cut-off was used for new syndromes because it
would allow infection syndromes to span multiple weeks
even if one weekly survey was missed. Missing weeks
were otherwise assumed to have no symptoms. Non-
specific symptoms could contribute to the duration of
infection syndromes in any category, but at least one
specific symptom had to be reported to define a syn-
drome in a given category, and non-specific symptoms
alone were not classified as infection syndromes. For ex-
ample, a headache reported in the absence of other in-
fection symptoms was not classified as an infection
syndrome as most headaches are not due to infection.
Specific symptoms in different categories reported con-
currently were classified as separate infection syndromes.
We calculated the proportion of infection syndromes in
which each symptom was reported.
In calculation of person-time denominators, we ex-
cluded the first 10 days of follow-up to remove prevalent
infection syndromes. If symptoms were reported in the
first 10 days, we started follow-up on the first day with
no symptoms. We calculated crude incidence rates for
each syndrome per person-year and by month. We also
calculated age- and sex-specific and adjusted rates,
weighting to the mid-2017 population structure of Eng-
land [20] using post-stratification (implemented through
the R ‘survey’ package [21]).
We calculated the proportion of infection syndromes
leading to different healthcare-seeking behaviours and
antibiotic use, overall and separately by sex and for
adults and children. We described antibiotics used by
drug name, source, prescription length, duration taken,
whether it was a delayed prescription (i.e. the antibiotic
was prescribed but with advice to delay its use in the ex-
pectation that symptoms will resolve first), and reasons
for not finishing the prescribed course.
To assess the duration of infection syndromes, we ex-
cluded syndromes that led to antibiotic use. For these
syndromes, we plotted survival curves showing propor-
tions with ongoing symptoms each day. We also sum-
marised the number of consecutive days on which each
individual symptom was reported. We estimated the
mean and median duration of syndromes by fitting log-
logistic models to account for right-censoring of data
(further details in Additional File 1).
To assess impacts of infection syndromes on adult
health-related quality of life, we converted EQ-5D-3L re-
sponses to an index value by mapping to a validated UK
data set ranging from one (full health) to zero (dead)
[22]. We identified the mean worst day by EQ-5D-3L
index value in each syndrome category and estimated
the mean quality-adjusted life day (QALD) loss by sub-
tracting daily index values from baseline measurements.
We used our estimates of duration of syndromes to cal-
culate the average QALD impact of each type of syn-
drome (further details Additional File 1).
All analyses and data management were conducted
using R version 3·6·1.
Results
Recruitment and follow-up
The total number of adults invited was 19,471, and 1063
(5%) signed up. Additional recruitment of other adults
(21) and children (158) in the households gave a total of
1242 people registered. Completion of weekly surveys
was fairly consistent over the follow-up time (Figure S2).
72% (782/1084) of adults completed 75% or more sur-
veys. Participants included in the analysis therefore com-
prised these 782 adults and the 91 children that they
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registered, a total of 873. The total included follow-up
time was 23,111 person-weeks (444 person-years).
Baseline characteristics of the cohort are shown in
Table 1. The mean age was 54 years; 60% (528/873)
of participants were female. Compared with the Well-
come Trust Monitor population, a larger proportion
of the Bug Watch cohort knew that antibiotics can
only be used to treat bacterial infections (556/782
adults in Bug Watch, 71% vs 41% in Wellcome Trust
Monitor) [18]. However, the proportion reporting
antibiotic use in the previous year was similar (134/
782 adults in Bug Watch, 17% vs 23% in Wellcome
Trust Monitor). Full details of the study cohort, those
who were excluded, and population comparisons are
shown in Additional File 1 (Table S1).
Characterisation and incidence of infection syndromes
A total of 40,590 symptoms were reported, with at least
one symptom reported by 689/873 (79%) participants.
The number and percentage of syndromes in which each
symptom was reported at any time are shown in Table
S2.
By combining symptoms of the same category into in-
fection syndromes, we identified a total of 1422 infection
syndromes (814 respiratory, 222 gastrointestinal, 123
mouth/dental, 111 skin/soft tissue, 87 urinary tract, and
65 eye). Crude and age- and sex-adjusted incidence rates
are shown in Table 2 (age and sex-specific rates in Table
S3). The age and sex-adjusted incidence rates (and 95%
CIs) per person-year were: respiratory 2·03 (1·83–2·26);
gastrointestinal 0.68 (0·55–0·83); mouth/dental 0·29
(0·22–0·38); skin/soft tissue 0·23 (0·18–0·30); urinary
tract 0·17 (0·11–0·25), and eye 0·14 (0·10–0·20). Respira-
tory tract infection syndromes showed a winter peak in
incidence but there were no clear seasonal variations for
other infection syndromes (Figure S3).
Healthcare-seeking behaviours and antibiotic use
The proportions of infection syndromes for which
healthcare advice was sought from different sources are
shown in Table S4. Overall, GP consultation (in person)
was reported most frequently (10% of all infection syn-
dromes, 137/1422), followed by visiting the pharmacy
(7%, 101/1422), finding information on the internet (6%,
83/1422), and going to hospital (4%, 59/1422). Few
people reported using NHS 111, walk-in centres or an
online doctor service. The numbers and proportions of
infection syndromes that led to any GP (in person or
telephone) or dentist consultation are shown in Fig. 1
and Table 2.
Antibiotic use for incident infection syndromes was re-
ported 168 times by 116/873 (13%) individuals. Overall,
10% (136/1422) infection syndromes led to use of at
least one antibiotic. The median number of days
between the first symptom and first prescription of an
antibiotic was three (interquartile range (IQR) 1–7).
Antibiotic use was highest for urinary tract syndromes,
for which 41% (36/87) syndromes resulted in at least
one antibiotic used (Table 2).
Antibiotics were most often obtained from GP pre-
scriptions (79/168, 47%), followed by hospital doctors
(31/168, 18%) and dentists (17/168, 10%) (Fig. 2). There
were two reports of using antibiotics that were not pre-
scribed for current symptoms (for example those left
over from another time). Amoxicillin was the most fre-
quently reported drug (Table S5). The majority of anti-
biotic prescriptions were for a course of up to 1 week
(136/152, 89%, where the course length was reported).
Most antibiotics were also reported as taken for up to 1
week (112/168, 67%). Four participants reported taking
an antibiotic for 4 weeks or longer; the longest duration
reported was 21 weeks (for respiratory tract symptoms).
Delayed prescriptions were reported five times and on
four occasions people reported not finishing their course
of antibiotics; reasons given were side effects, being told
to stop by their doctor, and that they were feeling better.
Symptom duration and impact on health-related quality
of life
There were 1255 infection syndromes which did not lead
to antibiotic use. At least a quarter of infection syn-
dromes of all categories except urinary tract and gastro-
intestinal lasted into a second week (Fig. 3). The
proportion of respiratory infection syndromes that lasted
more than 1 week was 37%, whereas 51% of gastrointes-
tinal infection syndromes had resolved before the third
day. The number of consecutive days of reporting of
specific symptoms are shown in Table S6 and Figure S4.
The estimated mean duration of syndromes, worst day
and estimated QALD loss are summarised in Tables 3
and 4. The worst mean recorded day by EQ-5D-3L index
was between the second and third day for all syndromes
except eye (6 days). All types of syndromes had an esti-
mated mean of less than one total QALD loss per syn-
drome, except mouth/dental (1·3 days). There was
insufficient power to detect a QALD impact for eye in-
fection syndromes. Mean overall and worst EQ-5D-3L
index scores are summarised in Table S9.
Discussion
We have measured incidence rates, frequencies of
healthcare seeking behaviours and antibiotic use, the
average duration of symptoms, and the impacts on
health-related quality of life for a range of common
acute infection syndromes in the community. Using a
novel and efficient method of data collection, we have
captured reports of over 40,000 symptoms of respiratory,
gastrointestinal, mouth/dental, skin/soft tissue, urinary
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Table 1 Baseline cohort characteristics




Unspecified or prefer not to say 2 0·2
Age group (years)







East Midlands 81 9·3
East of England 130 14·9
London 73 8·4
North East 60 6·9
North West 92 10·5
South East 172 19·7
South West 100 11·5
West Midlands 93 10·7
Yorkshire and The Humber 69 7·9
Index of multiple deprivation quintile









Mixed/ multiple ethnic background 10 1·1








10 or more 13 1·5
Number of antibiotic prescriptions in last 12 months
0 626 71·7
1 154 17·6
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tract, and eye infections across more than 440 person-
years of follow up. Most people did not seek medical ad-
vice about their symptoms and one in ten infection syn-
dromes led to antibiotic use. A considerable proportion
of people went to hospital for their symptoms (particu-
larly for urinary tract infection syndromes) but the
NHS111 service was not used often. Symptoms usually
resolved within a week with the worst day of symptoms
on average after 3 days.
To our knowledge, this is the first study to measure
community-level incidence rates across a range of infec-
tion syndromes, and there are no comparable estimates
from equivalent large-scales studies for most of the types
of syndromes covered. The incidence of respiratory tract
infection has been estimated in various settings [10, 23–
25] including two large UK cohorts (Flu Survey [23] and
Flu Watch [10]). Although these two studies used
slightly different case definitions to Bug Watch, and cov-
ered winter months rather than the whole year, the esti-
mates were comparable: 3·3 episodes of influenza-like
illness per person year (age-standardised) in Flu Survey
[23]; 1.7 episodes of any respiratory illness (crude) in Flu
Watch [10], and 2·03 syndromes per person year (age
and sex-adjusted) in Bug Watch. The IID2 study of in-
fectious intestinal disease in the UK estimated a rate of
0·52 episodes per person year (definite and probable
cases) [11], similar to our estimate of 0·68 gastrointes-
tinal syndromes per person year.
We found substantial clinical “icebergs” for all infec-
tion types in Bug Watch, with most syndromes not lead-
ing to medical consultation. This pattern has been
observed previously for respiratory tract [10, 24, 26–28]
and gastrointestinal [11, 29] infections, but contrasts
with evidence from a cross-sectional study of urinary
tract infections which found that 65% adult females in
England contacted a GP about their most recent episode
[30]. It is likely that this difference is due to omission of
less severe cases from the previous study, which involved
a one-off interview and relied on recall rather than pro-
spective symptom reporting. Pharmacies and the inter-
net were the other most frequently used sources of
information, but the NHS 111 service was not used
often. These findings suggest that interventions encour-
aging safe self-management, for example provision of
better information online and in pharmacies, may be ef-
fective across all infection categories. Further work could
also explore how to promote NHS 111, or to develop
online services with access to advice from nurses or
pharmacists, which could reduce use of GPs or Accident
and Emergency services for these syndromes.
Although most antibiotics reported in Bug Watch
were prescribed by GPs, a substantial proportion were
from hospital doctors and dentists (for mouth/dental in-
fections). This suggests that some patients may be
bypassing primary care services and highlights the need
for continued attention to antibiotic stewardship for
acute infections across healthcare settings. Despite evi-
dence that delayed prescriptions for respiratory tract in-
fections can reduce use of antibiotics with no difference
in symptoms or patient satisfaction [31], they were used
infrequently. Half of the antibiotics reported were pre-
scribed within 3 days of the onset of symptoms. There
Table 1 Baseline cohort characteristics (Continued)












Number reported (% of syndromes) Incidence per person-year (95% confidence interval)
GP (or dentista) consultations Any antibioticb Crude Age and sex-adjusted
Respiratory 814 75 (9·2) 52 (6·4) 1·98 (1·82–2·14) 2·03 (1·83–2·26)
Gastrointestinal 222 16 (7·2) 2 (0·9) 0·54 (0·46–0·62) 0·68 (0·55–0·83)
Mouth/Dental 123 35 (28·5) 12 (9·8) 0·30 (0·25–0·36) 0·29 (0·22–0·38)
Skin/Soft tissue 111 30 (27·0) 25 (22·5) 0·27 (0·22–0·33) 0·23 (0·18–0·30)
Urinary tract 87 31 (35·6) 36 (41·4) 0·21 (0·16–0·28) 0·17 (0·11–0·25)
Eye 65 7 (10·8) 9 (13·8) 0·16 (0·12–0·21) 0·14 (0·10–0·20)
aMouth/Dental infections only
bAny antibiotic prescribed or used for symptoms during infection syndrome (including those from sources other than the GP, see Fig. 2)
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may therefore be scope for wider use of “safety netting”
stewardship interventions that give GPs flexibility not to
have to prescribe an antibiotic immediately without
compromising patient safety.
We have estimated average symptom duration and im-
pacts on health-related quality of life for a range of in-
fection syndromes in the community. For respiratory
tract infections, our estimates were comparable to those
from Flu Watch (crude mean 9·8 days duration in Bug
Watch; 9·0 days for influenza-like-illness and 6·9 days for
other acute respiratory tract infections in Flu Watch;
mean 0·7 QALD lost per syndrome in Bug Watch; 0·93
for influenza-like illness and 0·26 for other acute respira-
tory tract infections in Flu Watch) [14]. Other previous
Fig. 1 Clinical ‘icebergs’: Number and proportion of infection syndromes leading to GP (or dentist) consultation
Fig. 2 Sources of antibiotics by infection syndrome
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Fig. 3 Proportion of infection syndromes ongoing by day


















762 6 (3–11) 9·8 (13·1) 6·8 (3·8–12·1) 11·2 (9·5–13·2)
Gastrointestinal 220 3 (1–7) 8·1 (21·5) 3·1 (1·5–6·4) 7·1 (5·3–9·4)
Mouth/Dental 111 6 (3–10) 9·6 (17·9) 5·8 (3·3–10·3) 9·5 (7·4–12·1)
Skin/Soft tissue 86 6 (3–9) 11·7 (19·9) 5·6 (2·6–12·3) 15·9 (8·8–28·7)
Eye 56 6 (3–10) 14·4 (29·2) 7·5 (3·7–15·1) 16·7 (9·3–29·9)
Urinary tract 51 3 (2–6) 5·9 (8·3) 3·6 (2·1–6·2) 5·6 (4·0–8·0)
CI Confidence interval, IQR Interquartile range, sd Standard deviation
aNumber of syndromes used to estimate duration (excludes syndromes treated with antibiotics)
bAge standardised
cBased on results from log-logistic models (see Additional File 1)
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estimates of duration have tended to be based on pa-
tients who initially presented at primary care, and are
therefore likely to have excluded less severe cases. This
includes estimates of lower respiratory tract infection
(average duration 3 weeks [32]) and urinary tract infec-
tion (mean 5 days of symptoms after GP consultation
for infections not treated with antibiotics [33]). To our
knowledge there are no other community-based esti-
mates of QALD loss for other infection types. We have
also provided data on the frequency and duration of in-
dividual symptoms of infection. These estimates will be
useful in informing messages about symptom expect-
ation for antibiotic stewardship campaigns and for mod-
elling cost effectiveness of potential interventions. In the
context of emerging infections such as COVID-19,
knowledge of the background frequency of symptoms
characteristic of the new infection (Table S10) could be
used to inform public health advice regarding testing
and self-isolation. For example, data from Bug Watch
have been used to estimate the baseline demand for
COVID-19 tests due to background cases of cough and
fever [34]. All data from the Bug Watch study are avail-
able so that different combinations of symptoms can be
assessed in future studies [35].
A limitation of this study was that a relatively low pro-
portion of people from the HSE sample responded to
the invitation to participate, and some did not consent
to be re-contacted about future research. The results
may therefore not be representative, with participants
more likely to be older, female, and living in less de-
prived areas than the general population. To partially ac-
count for this, we adjusted incidence rate estimates to
the age and sex structure of England and reported
healthcare-seeking behaviours separately for adults and
children and by sex. Whilst there are likely to be differ-
ences in healthcare-seeking behaviours for groups not
well represented in this study, our data provides
community-level information that is not easily obtained
from other study designs. Further work is needed to
understand how to engage a more diverse population in
future similar studies. All surveys for children were com-
pleted by their parents/guardians, and healthcare-
seeking behaviours are likely to have different drivers for
this group, which we plan to explore through future
qualitative interviews [36].
It is also possible that people who were motivated to
sign up to participate in Bug Watch tended to have
more infections or have a particular interest in antibiotic
stewardship. Comparisons with the Wellcome Trust
Monitor survey suggested that the Bug Watch cohort
had a greater awareness of antibiotic resistance but that
it was not reflected in large differences in behaviour in
terms of antibiotic use. Once registered, the retention of
the cohort was good, with 72% of people who signed up
completing at least three quarters of their weekly sur-
veys. This suggests that the online survey methodology
was acceptable and not too burdensome, so should be
considered for future similar studies. Our measures to
maintain engagement in the study included provision of
regular newsletters with study updates and small tokens
of appreciation (£5 vouchers) for those who completed
the majority of surveys.
We combined self-reported symptoms of infection on
different days into infection syndromes. This relied on
assumptions about the plausible length of time between
symptoms that could have been caused by the same in-
fection, and could have led to over- or under- ascertain-
ment of incidence rates. Although we asked participants
to only report symptoms that they suspected to be
caused by an acute infection, there was no microbio-
logical confirmation and it is likely that some symptoms
(for example symptoms due to chronic conditions or



















QALD loss per syndromec
Mean (95% CI) Median (IQR)
Respiratory tractb 663 3·2 (6·9) 0·06 (0·28) 0·7 (0·6–0·8) 0·4 (0·2–0·7)
Gastrointestinal 188 3·0 (9·7) 0·06 (0·34) 0·4 (0·3–0·5) 0·2 (0·1–0·4)
Mouth/Dental 102 3·5 (6·4) 0·14 (0·27) 1·3 (1·1–1·7) 0·8 (0·5–1·5)
Skin/Soft tissue 77 3·3 (6·1) 0·02 (0·29) 0·3 (0·2–0·6) 0·1 (0·1–0·3)
Eye 52 6·0 (16·0) -0·01 (0·28) -0·1 (0--0·2) -0·1 (0--0·1)
Urinary tract 49 2·7 (5·9) 0·09 (0·09) 0·5 (0·3–0·7) 0·3 (0·2–0·5)
CI Confidence interval, IQR Interquartile range, QALD Quality-adjusted life day, sd Standard deviation
aNumber of syndromes used to estimate duration (excludes syndromes treated with antibiotics, and those for children under 16)
b Age standardised
cCalculated by multiplying the mean QALD loss per day by the mean and median (respectively) duration estimates adjusted for right-censoring (Table 3)
Smith et al. BMC Infectious Diseases          (2021) 21:105 Page 9 of 11
allergies like hay fever) were mistakenly reported, leading
to overestimation of rates. Similarly, the self-reports of
healthcare-seeking behaviours were not corroborated
with health records, we do not have information on
overnight hospitalisation or death, and reports rely on
participants correctly interpreting the survey questions.
For example, if a participant initially phoned the NHS
111 service but were subsequently transferred to a tele-
phone GP, we cannot be sure if they would have in-
cluded both behaviours when completing the survey.
Conclusions
Most people are able to manage symptoms of common in-
fection without medical consultation. The information on
consultation and prescribing frequencies and symptom dur-
ation will be useful in the design of national and inter-
national antibiotic stewardship programs, public health
campaigns, and to support GPs in communicating with pa-
tients about infections. Interventions encouraging safe self-
management across a range of acute infection syndromes
could decrease pressure on primary healthcare services and
support targets for reducing antibiotic prescribing. Our
health-related quality of life estimates could be used to in
health economic models of the impacts of interventions.
The novel data on symptom duration and frequency that
we have captured is also valuable for assessing characteris-
tics of emerging infections such as COVID-19 [34].
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